Volume 19, Issue 4 (winter 2022)
Sci J Iran Blood Transfus Organ 2022, 19(4): 292-300 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shekeft M, Milani S, Sharifi Z, Oodi A. Establishment of lymphoblastoid cell line producing Anti-RhE antibody using alloimmune thalassemia patient's blood. Sci J Iran Blood Transfus Organ 2022; 19 (4) :292-300
URL: http://bloodjournal.ir/article-1-1454-en.html
URL: http://bloodjournal.ir/article-1-1454-en.html
Full-Text [PDF 396 kb]
(603 Downloads)
| Abstract (HTML) (896 Views)
Establishment of lymphoblastoid cell line producing Anti-RhE antibody using alloimmune thalassemia patient's blood
Shekeft M.1, Milani S.1, Sharifi Z.1, Oodi A.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
One of the applications of Epstein-Barr virus in research is the immortalization of B lymphocytes and the creation of the lymphoblastoid cell line. People with thalassemia usually need blood transfusion, the main complication of which is alloimmunization. Antibody against RhE antigen causes hemolytic reactions. The aim of this study is to create a lymphoblastoid cell line that produces anti-E using peripheral blood mononuclear cells of alloimmune thalassemia patients against E antigen when exposed to Epstein Bar Virus (EBV).
Materials and Methods
In an experimental study, the mononuclear cells of 3 patients were isolated by Ficol and mixed with EBV. The transformed cells were cultured in RPMI medium containing cyclosporine. After 2-3 weeks, the formation of clones in the wells was checked and the hemagglutination test was performed for the wells containing the growing cells; the total amount of antibody in positive wells was measured by ELISA method.
Results
Exposure of mononuclear cells of patients with EBV led to cell transformation and creation of clones in some wells. The results of hemagglutination and ELISA methods showed that the clones were able to produce antibodies against the RhE antigen.
Conclusions
Anti-E antibody-producing lymphoblastoid cell line can be created by using sensitized cells of thalassemia patients against RhE antigen and its immortalization by EBV transformation method.
Key words: Antibodies, Thalassemia, Alloimmunization, EBV
Received: 18 Jun 2022
Accepted: 27 Aug 2022
Correspondence: Milani S., PhD of Medical Biotechnology. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-369, Tehran, Iran. Tel: (+9821) 88993778; Fax: (+9821) 88993778
E-mail: s.milani@tmi.ac.ir
Full-Text: (890 Views)
References:
- Hanack K, Messerschmidt K, Listek M. Antibodies and Selection of Monoclonal Antibodies. Adv Exp Med Biol 2016; 917: 11-22.
- Lemskaya NA. A modified protocol for highly efficient EBV-mediated immortalization of human B lymphocytes from small volumes of peripheral blood serum. Egypt J Med Hum Genet 2018; 19(3): 221-3.
- Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 1(7335): 702-3.
- Cohen JI. Primary Immunodeficiencies Associated with EBV Disease. Curr Top Microbiol Immunol 2015; 390(Pt 1): 241-65.
- Sugimoto M, Tahara H, Ide T, Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 2004; 64(10): 3361-4.
- Movafagh A, Heydary H, Mortazavi-Tabatabaei SAR, Azargashb E. The significance application of indigenous Phytohemagglutinin (PHA) mitogen on metaphase and cell culture procedure. Iran J Pharm Res 2011; 10(4): 895-903.
- Muncie HLJ, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009; 80(4): 339-44.
- Viprakasit V, Ekwattanakit S. Clinical Classification, Screening and Diagnosis for Thalassemia. Hematol Oncol Clin North Am 2018; 32(2): 193-211.
- Azarkeivan A, Ansari S, Ahmadi MH, Hajibeigy B, Maghsudlu M, Nasizadeh S, et al. Blood transfusion and alloimmunization in patients with thalassemia: Multicenter study. Pediatr Hematol Oncol 2011; 28(6): 479-85.
- Pandey H, Das SS, Chaudhary R. Red cell alloimmunization in transfused patients: A silent epidemic revisited. Asian J Transfus Sci 2014; 8(2): 75-7.
- Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000; 95(2): 375-87.
- Ahmadi MH, Maroufi F, Kelki H, Zolghadri N, Moradi F, Maali A, et al. The incidence of ABO, Kell and Rh system blood groups in general population of Qazvin, Iran. Arch Adv Biosci 2018; 9(4): 42-6.
- Shahverdi E, Moghaddam M, Talebian A, Abolghasemi H. Distribution of blood groups in the Iranian general population. Immunohematology 2016; 32(4): 135-9.
- Moran P, Robson SC, Reid MM. Anti-E in pregnancy. BJOG 2000; 107(11): 1436-8.
- Hosseini MS, Jafari L, Shiri Heris R, Gharehbaghian A. Red blood cell alloimmunization in Iran: A Comprehensive review of the literature. Asian J Transfus Sci 2020; 14(1): 4-8.
- Alkindi S, AlMahrooqi S, AlHinai S, AlMarhoobi A, Al-Hosni S, Daar S, et al. Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman. Mediterr J Hematol Infect Dis 2017; 9(1): e2017013.
- Tousizadeh B, Moghim S, Chaleshtori ARS, Ghanbarian M, Mirian M, Salehi M, et al. Application of Epstein-Barr Virus for Optimization of Immortalized
B-lymphocyte Production as a Positive Control in Genetic Studies. Adv Biomed Res 2017; 6: 80. - Hui-Yuen J, McAllister S, Koganti S, Hill E, Bhaduri-Mcintosh S. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines. J Vis Exp 2011; 57: 3321.
- Fraussen J, Vrolix K, Martinez-Martinez P, Losen M, Meulemans E, De Baets MH, et al. A novel method for making human monoclonal antibodies. J Autoimmun 2010; 35(2): 130-4.
|
Sci J Iran Blood Transfus Organ 2022;19 (4): 292-300 |
|
Original Article
|
Establishment of lymphoblastoid cell line producing Anti-RhE antibody using alloimmune thalassemia patient's blood
Shekeft M.1, Milani S.1, Sharifi Z.1, Oodi A.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
One of the applications of Epstein-Barr virus in research is the immortalization of B lymphocytes and the creation of the lymphoblastoid cell line. People with thalassemia usually need blood transfusion, the main complication of which is alloimmunization. Antibody against RhE antigen causes hemolytic reactions. The aim of this study is to create a lymphoblastoid cell line that produces anti-E using peripheral blood mononuclear cells of alloimmune thalassemia patients against E antigen when exposed to Epstein Bar Virus (EBV).
Materials and Methods
In an experimental study, the mononuclear cells of 3 patients were isolated by Ficol and mixed with EBV. The transformed cells were cultured in RPMI medium containing cyclosporine. After 2-3 weeks, the formation of clones in the wells was checked and the hemagglutination test was performed for the wells containing the growing cells; the total amount of antibody in positive wells was measured by ELISA method.
Results
Exposure of mononuclear cells of patients with EBV led to cell transformation and creation of clones in some wells. The results of hemagglutination and ELISA methods showed that the clones were able to produce antibodies against the RhE antigen.
Conclusions
Anti-E antibody-producing lymphoblastoid cell line can be created by using sensitized cells of thalassemia patients against RhE antigen and its immortalization by EBV transformation method.
Key words: Antibodies, Thalassemia, Alloimmunization, EBV
Received: 18 Jun 2022
Accepted: 27 Aug 2022
Correspondence: Milani S., PhD of Medical Biotechnology. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-369, Tehran, Iran. Tel: (+9821) 88993778; Fax: (+9821) 88993778
E-mail: s.milani@tmi.ac.ir
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
